According to reports, FBLN2 has been identified to exhibit tumour suppressor properties in several cancer types, such as breast cancer,28 non‐small cell lung cancer,29 and nasopharyngeal carcinoma.30 The gene discussed is FBLN2; the disease is lung cancer.